NIH-funded research Sbir 2 grant

A new rapid test for Brugia parasite infection

Official title: Supporting WHO Lymphatic Filariasis Elimination Programs: Progressing a Highly Sensitive and Specific Rapid Diagnostic Test for Brugia Species Infection to Commercialization Readiness

Funded at Big Eye Diagnostics, INC. · NIH-11079584 · Data updated 2026-11-12

This project is developing a quick and accurate test to find Brugia parasite infections, which cause lymphatic filariasis, to help eliminate the disease.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionBig Eye Diagnostics, INC.
NIH-funded
Lab location1 site (San Diego, United States)
Project startMay 1, 2024
Project endApril 30, 2027
Funding year2025
Award (this year)$396,523
NIH project number5R44AI184015-02
Project IDNIH-11079584 on NIH RePORTER

Who could benefit from this research

Could help

This research is primarily for individuals in regions affected by lymphatic filariasis caused by Brugia species, particularly in Southeast Asia, who may need testing for the infection.

Less likely to help

Patients with lymphatic filariasis caused by other parasite species, such as Wuchereria bancrofti, may not directly benefit from this specific Brugia-focused test.

What this research studies

We are working to make a new, easy-to-use rapid diagnostic test, called Brugia Test Plus (BT+), widely available. This test helps identify infections caused by Brugia parasites, which lead to a painful and disfiguring disease called lymphatic filariasis. The BT+ test has already shown excellent results in lab settings and promising results in field tests, meeting important global health standards. Our goal is to quickly move this test into manufacturing and distribution so it can be used in areas where the disease is common.

Why it matters

Potential benefit: If successful, this new test could help identify infections earlier and more accurately, supporting global efforts to eliminate lymphatic filariasis and prevent its debilitating effects.

How similar studies have gone: The Brugia Test Plus (BT+) has already demonstrated high sensitivity and specificity in laboratory and initial field testing, building on previous development phases.

Where this research is happening

  • Big Eye Diagnostics, INC.
    San Diego, United States
    Active

Researchers

  • Principal investigator: Biamonte, Marco Antonio — Big Eye Diagnostics, INC.
  • Study coordinator: Biamonte, Marco Antonio

Related research

Other NIH-funded projects on the same topics.

  • Finding new ways to diagnose neglected tropical diseases.

    This study is looking for new ways to help doctors find and diagnose certain tropical diseases caused by parasites, so that patients can get the right treatment more easily and quickly.

    NIH research Big Eye Diagnostics, INC. · San Diego, United States · NIH-11306897

  • A low-cost test for diagnosing Hepatitis B, Hepatitis C, and HIV infections.

    This study is working on a simple test that you can use at home to check for Hepatitis B, Hepatitis C, and HIV, making it easier for people, especially in areas with fewer resources, to get the health care they need.

    NIH research Big Eye Diagnostics, INC. · San Diego, United States · NIH-11170172

  • Rapid, ultra-sensitive test for detecting lymphatic filariasis

    This project is making an inexpensive, easy-to-use rapid strip test to find early Wuchereria bancrofti infections so people and health teams in affected communities can detect and act sooner.

    NIH research Big Eye Diagnostics, INC. · San Diego, United States · NIH-11137772

  • A rapid test to detect lymphatic filariasis infections

    This study is working on a new, easy-to-use test that can quickly and accurately detect lymphatic filariasis, a disease caused by a parasite, to help communities monitor and manage the disease better, especially after treatment programs.

    NIH research Big Eye Diagnostics, INC. · San Diego, United States · NIH-11083346

  • Developing a new rapid test for river blindness diagnosis

    This study is working on a quick and accurate test for river blindness to help health organizations better target treatments for those affected, and it will involve around 10,000 people to make sure the test works well in real life.

    NIH research Big Eye Diagnostics, INC. · San Diego, United States · NIH-10810633

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.